Allied Market Research published a report, titled, “Idiopathic Pulmonary Fibrosis Market by Drug Type (Nintedanib, and Pirfenidone) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030.” According to the report, the global Idiopathic Pulmonary Fibrosis Market Size was Valued at USD 3.12 billion in 2020 and is …
Tag Archives: Idiopathic Pulmonary Fibrosis Market Growth
Idiopathic Pulmonary Fibrosis Market Size Revenue to Cross USD 6.16 billion by 2030
According to the report published by Allied Market Research, Global Idiopathic Pulmonary Fibrosis Market Size Was Valued at USD 3.12 billion in 2020 and is Projected to Garner USD 6.16 billion by 2030, witnessing a CAGR of 7.0% from 2021 to 2030. Increase in incidences of cancer worldwide, favorable reimbursement policies provided by manufacturers & insurance providers, and rise in cigarette smoking …
Idiopathic Pulmonary Fibrosis Market Insights by Emerging Trends, Growth, and Forecast by 2030 | At a CAGR of 7.0%
Increase in incidences of cancer worldwide, favorable reimbursement policies provided by manufacturers & insurance providers, and rise in cigarette smoking drive the growth of the global idiopathic pulmonary fibrosis market. However, the unavailability of the proper treatment options restrains the market growth. On the other hand, rise in number of pipeline drugs and untapped potential …